Asthma Clinical Research Network is categorized under Medical Labs in La Jolla, CA and active since 2010.
Asthma Clinical Research Network was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Reuben Cherniack at the company’s single location by writing to 9500 Gilman Drive Department 637, La Jolla, California CA 92093 or by phoning (858) 822-4261. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Asthma Clinical Research Network |
| Contact Person: | Reuben Cherniack |
| Address: | 9500 Gilman Drive Department 637, La Jolla, California 92093 |
| Phone Number: | (858) 822-4261 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Asthma Clinical Research Network was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Reuben Cherniack for inquiries that concern Asthma Clinical Research Network by calling the company number (858) 822-4261, as your correspondence is most welcome. Additionally, the physical location of the single location of Asthma Clinical Research Network can be found at the coordinates 32.872708,-117.237572 as well as the street address 9500 Gilman Drive Department 637 in La Jolla, California 92093.
For its online presence, you may visit Asthma Clinical Research Network’s website at and engage with its social media outlets through on Twitter and on Facebook.